LEP and breast carcinoma: Accordingly, we measured changes in cellular migration in highly invasive breast cancer cells (MDA-MB-231) which had high ATP production by glycolysis (Fig. 3d), treated with leptin, CQ, or oxidative phosphorylation (OXPHOS) inhibitors that prevent mitochondrial ATP formation (oligomycin and antimycin A).